ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

NCI To Expand SPORE Grants Program to Increase Translational Research Funding

October 22, 1999

NCA Declines To Set Minimum Comp Center Bed Number

April 2, 1976

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007

Southwest Oncology Group Becomes “SWOG”

April 8, 2011

Feinstein Reintroduces New National Cancer Act

June 13, 2003

ARRA Funding Announcements Listed

April 10, 2009